Compare STRL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | ELAN |
|---|---|---|
| Founded | 1955 | 1954 |
| Country | United States | United States |
| Employees | 1740 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 12.7B |
| IPO Year | 1996 | 2018 |
| Metric | STRL | ELAN |
|---|---|---|
| Price | $459.66 | $23.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $443.33 | $27.63 |
| AVG Volume (30 Days) | 428.6K | ★ 5.5M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.42 | N/A |
| EPS | ★ 9.38 | N/A |
| Revenue | $957,958,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $26.86 | $8.21 |
| Revenue Next Year | $11.52 | $5.29 |
| P/E Ratio | $47.63 | ★ N/A |
| Revenue Growth | ★ 38.81 | 6.22 |
| 52 Week Low | $129.21 | $8.02 |
| 52 Week High | $477.03 | $27.72 |
| Indicator | STRL | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 49.76 |
| Support Level | $303.13 | $23.72 |
| Resistance Level | $469.22 | $25.65 |
| Average True Range (ATR) | 25.12 | 1.04 |
| MACD | 3.74 | -0.01 |
| Stochastic Oscillator | 99.24 | 48.04 |
Sterling Infrastructure Inc operates through subsidiaries within three segments: E-Infrastructure, Transportation, and Building Solutions in the United States, mainly across the Southern, Northeastern, Mid-Atlantic, and Rocky Mountain regions and the Pacific Islands. E-Infrastructure Solutions generates maximum revenue and provides site development and mission-critical electrical services for data centers, manufacturing, distribution centers, warehousing, and power generation. Transportation Solutions includes infrastructure and rehabilitation projects for highways, airports, ports, rail, and storm drainage systems. Building Solutions includes residential and commercial concrete foundations, parking structures, plumbing services, and surveys for new single-family residential builds.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.